Is a complete IST/ORZAX research report available?

No complete published report is available for ist/ORZAX (IST/ORZAX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

IST/ORZAX (IST/ORZAX)

Istanbul Stock Exchange: IST/ORZAX · TRY

TRY 104

+2.80 (+2.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-02 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first IST/ORZAX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	35.2B
Revenue (ttm)	8.1B
Net income (ttm)	1.3B
EPS (ttm)	TRY 4.11
Shares out	338.5M
P/E (trailing)	25.3x
Volume	10,826,443

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 8.1B
Net income (ttm): 1.3B
EPS (ttm): TRY 4.11
P/E (trailing): 25.3x
Market cap: 35.2B

All IST/ORZAX indicators

Market & fundamental data

Available fields

132

Groups with data

Currency

TRY

Showing 132 of 132 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Turkey
Country code	TR
Employees	1,011
Employees Change	43%
Employees Change Percent	4.44
Enterprise value	TRY 38.6B
Exchange	Istanbul Stock Exchange
Financial currency	TRY
First seen	2026-07-12
Industry	Pharmaceutical Preparations
Last refreshed	2026-08-02
Market cap	TRY 35.2B
Price	TRY 104
Price currency	TRY
Rev Per Employee	7,980,998.57x
Sic	2834
Symbol	ist/ORZAX
Website	https://www.orzax.com.tr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.58%
EV Earnings	30.59x
EV/EBIT	14.56x
EV/EBITDA	13.43x
EV/Sales	4.78x
FCF yield	-2.08%
P/B ratio	10.55x
P/E ratio	25.32x
P/S ratio	4.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.83%
EBITDA Margin	34.91%
Gross margin	64.7%
Gross Profit	TRY 5.2B
Net Income	TRY 1.3B
Pretax Margin	22.72%
Profit Margin	15.63%
Profit Per Employee	TRY 1.2M
ROCE	58.15
ROIC	26.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	28.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	TRY 9.8B
Cash	TRY 1B
Current Assets	TRY 8.5B
Current Liabilities	TRY 5.3B
Debt	TRY 4.4B
Debt EBITDA	TRY 1.53
Debt Equity	TRY 1.31
Debt FCF	TRY -5.98
Equity	TRY 3.3B
Interest Coverage	2.48
Liabilities	TRY 6.5B
Long Term Assets	TRY 1.3B
Long Term Liabilities	TRY 1.2B
Net Cash	TRY -3.4B
Net Cash By Market Cap	TRY -9.59
Net Debt EBITDA	TRY 1.2
Net Debt Equity	TRY 1.01
Tangible Book Value	TRY 3.1B
Tangible Book Value Per Share	TRY 10.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.61
Net Working Capital	TRY 5.6B
Quick ratio	1.05
Working Capital	TRY 3.2B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Payout Ratio	69.94%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
All Time High	113.6
All Time High Change	-8.45%
All Time High Date	2026-07-16
All Time Low	69
All Time Low Change	50.72%
All Time Low Date	2026-07-03
ATR	8.07
Beta1y	-2.35
High	106.9
High52	113.6
High52 Date	2026-07-16
High52ch	-8.45%
Low	100.2
Low52	69
Low52 Date	2026-07-06
Low52ch	50.73%
RSI	69.4
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	6.89x
Sortino ratio	17.1
Tr1w	1.96%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TRY 2.6B
Operating margin	32.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	52,500,000%
Net Borrowing	2,799,514,650
Shares Insiders	31.89%
Shares Out	338,500,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	32,331,755.85x
Bv Per Share	10.87
CAPEX	TRY -593.9M
Ch1w	1.96
Change	2.77%
Change From Open	2.16
Close	101.2
Days Gap	0.59
Depreciation Amortization	167,826,359
Dollar Volume	1,125,950,072
Earnings Date	2026-09-24
EBIT	TRY 2.6B
EBITDA	TRY 2.8B
EPS	TRY 4.11
F Score	1
FCF	TRY -732.9M
FCF EV Yield	-1.9x
FCF Per Share	TRY -2.17
Financing CF	1,547,614,866
Fiscal Year End	December
Founded	2,004
Graham Number	31.69298
Graham Upside	-69.53
Income Tax	TRY 572.4M
Investing CF	-579,651,857
Is Primary Listing	1
Last Report Date	2026-03-31
Net CF	765,099,605
Next Earnings Date	2026-09-24
Open	101.8
Position In Range	56.72
Ppne	1,100,083,251
Price Date	2026-07-31
Price EBITDA	TRY 12.5
Ptbv Ratio	11.29
Relative Volume	0.32x
Revenue	8,068,789,555x
Tax By Revenue	7.09x
Tax Rate	31.22%
Volume	10,826,443
Z Score	2.39

IST/ORZAX (IST/ORZAX)

Coverage state: Market snapshot only — no published research

Generate the first IST/ORZAX analysis

Price

Financial snapshot

Fair-value bridge

Latest news · IST/ORZAX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IST/ORZAX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on IST/ORZAX

Frequently asked questions